Unity Biotechnology Names Federico Grossi Chief Medical …
Jan 6, 2025 · Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive …
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse …
UNITY Biotechnology Announces Appointment of Federico Grossi…
Grossi oversaw the clinical strategy and development programs in ophthalmology, hematology, neurology and nephrology, leading to the approval and commercial launch of EMPAVELI …
UNITY Biotechnology Appoints Federico Grossi, M.D., Ph.D., as
Jan 6, 2025 · UNITY Biotechnology has appointed Federico Grossi, M.D., Ph.D., as its new chief medical officer to enhance its leadership team. Dr. Grossi, who has over 20 years of …
UNITY Biotechnology Announces Appointment of Federico Grossi…
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse …
UNITY Biotechnology Welcomes Dr. Grossi as New CMO to Lead …
Jan 6, 2025 · UNITY Biotechnology, a pioneering firm in the biotechnology sector devoted to combating the effects of aging, has made a significant enhancement to its leadership with the …
UNITY Biotechnology Announces Appointment of Federico Grossi …
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse …
UNITY Biotechnology (UBX) Appoints Federico Grossi as Chief …
Jan 6, 2025 · UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today strengthened the …
Unity Biotechnology Names Federico Grossi Chief Medical …
Jan 6, 2025 · Federico Grossi said he is looking forward to advance UBX1325, and advance pipeline to provide new and differentiated treatment options for patients with progressive …
UNITY Biotechnology Appoints Federico Grossi as Chief Medical …
Jan 6, 2025 · UNITY Biotechnology, Inc. appointed Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development and regulatory …
- Some results have been removed